RT @DrDamianDowney: The challenges of #antibiotic choice in #CF escalate with #resistance, allergies and efficacy. How do we do #trials? ht…
RT @DrDamianDowney: The challenges of #antibiotic choice in #CF escalate with #resistance, allergies and efficacy. How do we do #trials? ht…
RT @DrDamianDowney: The challenges of #antibiotic choice in #CF escalate with #resistance, allergies and efficacy. How do we do #trials? ht…
RT @CFAware: Single versus combination intravenous anti-pseudomonal antibiotic therapy for people with cystic fibrosis https://t.co/EH5Kky…
The challenges of #antibiotic choice in #CF escalate with #resistance, allergies and efficacy. How do we do #trials? https://t.co/fPAZTgyAKU
Single versus combination intravenous anti-pseudomonal antibiotic therapy for people with cystic fibrosis https://t.co/EH5KkyG46d
A comparison of single and combined intravenous drug therapy for people with cystic… https://t.co/muS5bmqOlX